Article
Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study.
Virology journal - 1 Oct 2018
Tao Ya-Chao, Deng Rong, Wang Meng-Lan, Lv Duo-Duo, Yuan Man, Wang Yong-Hong, Chen En-Qiang, Tang Hong
Abstract excerpt
BACKGROUND: Chronic hepatitis C virus (HCV) genotype (GT) 3 infection with advanced liver disease has emerged as a challenging to treat by direct-acting antivirals (DAAs), but the efficacy of DAAs in Chinese HCV-GT3 patients is rarely reported. This study aimed to analyze the efficacy of sofosbuvir (SOF)-based regimens in Chinese patients with HCV-GT3 and compensated liver disease. METHODS: This was a registered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.